Publication: Prognostic risk factors in ventilator-associated pneumonia
dc.contributor.buuauthor | Karakuzu, Ziyaettin | |
dc.contributor.buuauthor | İşçimen, Remzi | |
dc.contributor.buuauthor | Akalın, Halis | |
dc.contributor.buuauthor | Girgin, Nermin Kelebek | |
dc.contributor.buuauthor | Kahveci, Ferda | |
dc.contributor.buuauthor | Sınırtaş, Melda | |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Anesteziyoloji ve Reanimasyon Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Mikrobiyoloji ve Enfeksiyon Hastalıkları Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0001-8111-5958 | tr_TR |
dc.contributor.researcherid | FAL-0396-2022 | |
dc.contributor.researcherid | HKP-2533-2023 | |
dc.contributor.researcherid | AAU-8952-2020 | |
dc.contributor.researcherid | AAH-7250-2019 | |
dc.contributor.researcherid | CYR-2043-2022 | |
dc.contributor.researcherid | DSE-4824-2022 | |
dc.contributor.scopusid | 56088206300 | tr_TR |
dc.contributor.scopusid | 16645821200 | tr_TR |
dc.contributor.scopusid | 57207553671 | tr_TR |
dc.contributor.scopusid | 55663009300 | tr_TR |
dc.contributor.scopusid | 6602405968 | tr_TR |
dc.contributor.scopusid | 6505818048 | tr_TR |
dc.date.accessioned | 2024-03-27T07:21:25Z | |
dc.date.available | 2024-03-27T07:21:25Z | |
dc.date.issued | 2018-03-05 | |
dc.description.abstract | Background: Ventilator-associated pneumonia (VAP) is a nosocomial infection commonly seen in patients in intensive care units (ICU). This study aimed to analyze factors affecting prognosis of patients diagnosed with VAP. Material/Methods: Critically ill patients with VAP were retrospectively evaluated between June 2002 and June 2011 in the ICU. VAP diagnosis was made according to 2005 ATS/IDSA (Infectious Diseases Society of America/American Thoracic Society) criteria. First pneumonia attacks of patients were analyzed. Results: When early-and late-onset pneumonia causes were compared according to ICU and hospital admittance, resistant bacteria were found to be more common in pneumonias classified as early-onset according to ICU admittance. APACHE II score of >21 (p=0.016), SOFA score of >6 (p<0.001) on admission to ICU and SOFA score of >6 (p<0.001) on day of diagnosis are risk factors affecting mortality. Additionally, low PaO2/FIO2 ratio at onset of VAP had a negative effect on prognosis (p<0.001). SOFA score of >6 on the day of VAP diagnosis was an independent risk factor for mortality [(p<0.001; OR (95% CI): 1.4 (1.2-1.6)]. Conclusions: Resistant bacteria might be present in early-onset VAP. Especially, taking LOS into consideration may better estimate the presence of resistant bacteria. Acinetobacter baumannii, Pseudomonas aeruginosa, and methicillin-resistant Staphylococcus aureus (MRSA) were the most frequent causative microorganisms for VAP. SOFA score might be more valuable than APACHE II score. Frequently surveilling SOFA scores may improve predictive performance over time. | en_US |
dc.identifier.citation | Karakuzu, Z. vd. (2018). ''Prognostic risk factors in ventilator-associated pneumonia''. Medical Science Monitor, 24, 1321-1328. | en_US |
dc.identifier.doi | https://doi.org/10.12659/MSM.905919 | |
dc.identifier.endpage | 1328 | tr_TR |
dc.identifier.issn | 1643-3750 | |
dc.identifier.pubmed | 29503436 | tr_TR |
dc.identifier.scopus | 2-s2.0-85042930166 | tr_TR |
dc.identifier.startpage | 1321 | tr_TR |
dc.identifier.uri | https://medscimonit.com/abstract/index/idArt/905919 | |
dc.identifier.uri | https://hdl.handle.net/11452/40633 | |
dc.identifier.volume | 24 | tr_TR |
dc.identifier.wos | 000427517100001 | |
dc.indexed.pubmed | PubMed | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | International Scientific Information | en_US |
dc.relation.journal | Medical Science Monitor | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Research & experimental medicine | en_US |
dc.subject | Mortality | en_US |
dc.subject | Organ dysfunction scores | en_US |
dc.subject | Pneumonia, ventilator-associated | en_US |
dc.subject | Risk factors | en_US |
dc.subject | Intensive-care-unit | en_US |
dc.subject | Continuous mechanical ventilation | en_US |
dc.subject | Critical-ill patients | en_US |
dc.subject | Tracheal colonization | en_US |
dc.subject | Antibiotic-therapy | en_US |
dc.subject | Septic shock | en_US |
dc.subject | Apache-ll | en_US |
dc.subject | Mortality | en_US |
dc.subject | Infections | en_US |
dc.subject | Initiation | en_US |
dc.subject.emtree | Corticosteroid | en_US |
dc.subject.emtree | Acinetobacter baumannii | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | APACHE | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Artificial ventilation | en_US |
dc.subject.emtree | Bacteremia | en_US |
dc.subject.emtree | Dialysis | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Glasgow coma scale | en_US |
dc.subject.emtree | Hospital admission | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Klebsiella pneumoniae | en_US |
dc.subject.emtree | Length of stay | en_US |
dc.subject.emtree | Major clinical study | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Middle aged | en_US |
dc.subject.emtree | Mortality | en_US |
dc.subject.emtree | Oxygen tension | en_US |
dc.subject.emtree | Positive end expiratory pressure | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Pseudomonas aeruginosa | en_US |
dc.subject.emtree | Receiver operating characteristic | en_US |
dc.subject.emtree | Retrospective study | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Sequential organ failure assessment score | en_US |
dc.subject.emtree | Tidal volume | en_US |
dc.subject.emtree | Ventilator associated pneumonia | en_US |
dc.subject.emtree | Antibiotic resistance | en_US |
dc.subject.emtree | Cross infection | en_US |
dc.subject.emtree | Intensive care unit | en_US |
dc.subject.emtree | Methicillin resistant Staphylococcus aureus | en_US |
dc.subject.emtree | Pathogenicity | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Pneumonia | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Risk factor | en_US |
dc.subject.emtree | Ventilator associated pneumonia | en_US |
dc.subject.mesh | Acinetobacter baumannii | en_US |
dc.subject.mesh | Cross infection | en_US |
dc.subject.mesh | Drug resistance, bacterial | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Intensive care units | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Methicillin-resistant staphylococcus aureus | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Pneumonia | en_US |
dc.subject.mesh | Pneumonia, ventilator-associated | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.subject.mesh | Pseudomonas aeruginosa | en_US |
dc.subject.mesh | Respiration, artificial | en_US |
dc.subject.mesh | Retrospective studies | en_US |
dc.subject.mesh | Risk factors | en_US |
dc.subject.scopus | Ventilator Associated Pneumonia; Anti-Bacterial Agents; Piperacillin Plus Tazobactam | en_US |
dc.subject.wos | Medicine, research & experimental | en_US |
dc.title | Prognostic risk factors in ventilator-associated pneumonia | en_US |
dc.type | Article | en_US |
dspace.entity.type | Publication |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: